Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 33: 1856-1862, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, M. B.
Right arrow Articles by Popp, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, M. B.
Right arrow Articles by Popp, J. A.

Clinical Chemistry, Vol 33, 1856-1862, Copyright © 1987 by American Association for Clinical Chemistry

Validation and application of a liquid-chromatographic/enzymatic assay for individual bile acids in the serum of rats

MB Thompson, PC Blair, RW Morris, DA Neptun, DF Deyo and JA Popp
National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

A liquid-chromatographic technique with a post-column enzymatic reaction and fluorescence detection was validated for analysis of individual bile acids in the serum of rats. Extraction recoveries averaged 91.1% (SD 6.9%) for all bile acids. The assay was sensitive (minimum detection of 16.8 pmol per 100-microL injection), linear (r greater than 0.999 for concentrations ranging between 45 and 112,500 pmol per 100-microL injection), and reproducible (mean CVs for three different concentrations of standards and a serum pool ranged from 4.4% to 12.2%). In rats treated for three days with either neomycin, carbon tetrachloride, alpha-naphthylisothiocyanate, or total bile-duct ligation (five animals per group), total concentrations of bile acids were significantly increased (P less than 0.004). Concentrations of 16 of 17 individual bile acids differed significantly between groups (P less than 0.04). Examination of the relative concentrations (percent of total) of individual bile acids by canonical discriminant analysis placed each animal into the appropriate treatment or control group. Use of this technique in toxicological studies can help detect and identify specific types of disruptions in the enterohepatic circulation of bile acids.


The following articles in journals at HighWire Press have cited this article:


Home page
Toxicol PatholHome page
M.B. Thompson
Bile Acids in the Assessment of Hepatocellular Function
Toxicol Pathol, January 1, 1996; 24(1): 62 - 71.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
K. W. Weingand, M. Carakostas, R. L. Hall, and D. Neptun
Clinical Pathology Testing Recommendations, DACC-ASVCP Regulatory Task Force Response
Toxicol Pathol, November 1, 1993; 21(6): 655 - 656.
[PDF]


Home page
Toxicol PatholHome page
G.O. Evans
Clinical Pathology Testing Recommendations for Nonclinical Toxicity and Safety Studies
Toxicol Pathol, September 1, 1993; 21(5): 513 - 514.
[PDF]


Home page
Toxicol PatholHome page
K. Weingand, J. Bloom, M. Carakostas, R. Hall, M. Helfrich, K. Latimer, B. Levine, D. Neptun, A. Rebar, K. Stitzel, et al.
Clinical Pathology Testing Recommendations for Nonclinical Toxicity and Safety Studies
Toxicol Pathol, January 1, 1992; 20(3-2): 539 - 543.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.